flumazenil has been researched along with lactulose in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Perney, P; Pomier-Layrargues, G | 1 |
| Bañares, R; Carneros, JA; Rincón, D | 1 |
| Blei, AT | 1 |
| Blei, AT; Córdoba, J | 1 |
| Helewski, KJ; Konecki, JJ; Kowalczyk-Ziomek, GI | 1 |
| Carmona Soria, I; García Montes, JM; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Quero Guillén, JC | 1 |
| Foster, KJ; Lin, S; Turck, CJ | 1 |
| Mahpour, NY; Pioppo-Phelan, L; Reja, M; Rustgi, VK; Tawadros, A | 1 |
7 review(s) available for flumazenil and lactulose
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Hepatic encephalopathy. Physiopathology and treatment].
Topics: Amino Acids; Anti-Bacterial Agents; Drug Therapy, Combination; Flumazenil; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Portacaval Shunt, Surgical | 1994 |
[New treatments of hepatic encephalopathy].
Topics: Amino Acids, Branched-Chain; Animals; Benzoates; Benzoic Acid; Clinical Trials as Topic; Electrocardiography; Female; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Magnesium; Male; Rats; Zinc | 1998 |
Brain edema and portal-systemic encephalopathy.
Topics: Brain; Brain Edema; Flumazenil; Glutamine; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Necrosis; Prognosis | 2000 |
[Therapeutic management of hepatic encephalopathy].
Topics: Anti-Bacterial Agents; Disease Progression; Flumazenil; Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation; Treatment Outcome | 2002 |
Current and emerging strategies for treating hepatic encephalopathy.
Topics: Acarbose; Anti-Bacterial Agents; Carnitine; Dyskinesias; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Probiotics; Risk Factors | 2010 |
Pharmacologic Management of Hepatic Encephalopathy.
Topics: Acarbose; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Glycoside Hydrolase Inhibitors; Hepatic Encephalopathy; Humans; Lactulose; Laxatives; Phenylbutyrates; Probiotics; Rifaximin | 2020 |
4 other study(ies) available for flumazenil and lactulose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Hepatic Encephalopathy.
Topics: Adult; Bromocriptine; Dietary Proteins; Digestive System; Flumazenil; Gastrointestinal Agents; Goals; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neurotransmitter Agents; Nitrogen; Splanchnic Circulation; Therapeutic Irrigation | 2001 |
Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bromocriptine; Dipeptides; Dopamine Agonists; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure, Acute; Liver Transplantation; Neomycin; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Prognosis; Sodium Benzoate; Terminology as Topic; Time Factors; Zinc | 2003 |